A Study of Acupuncture for Treating Asthma

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-70
SponsorShanghai University of Traditional Chinese Medicine

About this trial

Asthma is a common chronic respiratory disease with a low clinical control rate, highlighting the need for novel therapeutic strategies. Recurrent asthma attacks emotional symptoms, such as anxiety and depression, etc. On the contrary, symptoms such as anxiety and depression worsen asthma control. Acupuncture is commonly applied as an effective traditional Chinese medical therapy for asthma. Acupoints GV14, BL13 and BL12 are adopted for the intervention of asthma. GV20 and GV29 are selected to improve emotional symptoms including depression. Nevertheless, standardized therapeutic regimens of acupuncture for asthma and its concomitant emotional symptoms are still lacking. 180 patients with mild to moderate asthma will be recruited in this multicenter randomized controlled trial, randomly assigned to the true acupuncture group, sham acupuncture group and usual care group. The primary outcome is the score of the Asthma Control Test (ACT). Secondary outcomes include the Hospital Anxiety and Depression Scale (HADS), Asthma Quality of Life Questionnaire (AQLQ), pulmonary function, and fractional exhaled nitric oxide (FeNO). The superiority of combined acupuncture therapy in improving asthma control, relieving negative emotions, and enhancing quality of life is to be verified in this study, with high quality evidence for acupuncture treatment of asthma thereby to be provided.

Eligibility criteria

Qualifiers

Meet the diagnostic criteria for asthma, and be in the chronic persistent phase with mild to moderate disease severity, referring to the grading criteria of the Guidelines for the Prevention and Treatment of Asthma (2024 Edition).

Aged 18 to 70 years, regardless of gender.

Asthma Control Test (ACT) score≤19 points (poorly controlled or very poorly controlled asthma).

Maintain a stable asthma treatment regimen for at least 4 weeks before enrollment.

Disqualifiers

Complicated with severe mental illnesses (such as uncontrolled schizophrenia, acute phase of bipolar disorder, etc.) or moderate to severe cognitive impairment (such as dementia), resulting in inability to understand the research process or cooperate with efficacy evaluation.

A history of substance/alcohol dependence within the past 12 months.

Complicated with other physical diseases that may cause depressive symptoms (such as hypothyroidism, chronic pain syndrome, malignant tumors, rheumatoid arthritis, etc.).

Received antidepressant drug treatment within the past 6 months.

Trial design

Treatments tested in this trial

  • Acupuncture
  • Sham Acupuncture
  • Usual Care

Treatment groups

180 Participants
are divided into 3 treatment groups

Locations

This trial has no locations

Sponsors and collaborators

Shanghai University of Traditional Chinese Medicine

Lead sponsor

Shanghai Municipal Hospital of Traditional Chinese Medicine

Sponsor institution

Shanghai Municipal Hospital of Traditional Chinese Medicine

Collaborator

Longhua Hospital

Collaborator

Shanghai Yueyang Integrated Medicine Hospital

Collaborator